<div>MS News Today columnist and forums moderator Ed Tobias reports on the FDA’s approval of Zeposia as a new disease-modifying therapy.</div>
<div>Are you interested in learning more about Multiple Sclerosis? If so, please visit <a href="https://multiplesclerosisnewstoday.com/">https://multiplesclerosisnewstoday.com/</a>
</div>

MS News Today columnist and forums moderator Ed Tobias reports on the FDA’s approval of Zeposia as a new disease-modifying therapy. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/

MS News Today columnist and forums moderator Ed Tobias reports on the FDA’s approval of Zeposia as a new disease-modifying therapy.
Are you interested in learning more about Multiple Sclerosis? If so, please visit <a href="https://multiplesclerosisnewstoday.com/" rel="noopener noreferrer">https://multiplesclerosisnewstoday.com/</a>


Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy

Multiple Sclerosis News Today seeks to fill an unmet need in healthcare news journalism by providing patients and their families with a reliable news journal on MS that they can engage with on a daily basis for the latest news and MS resources.

Share Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy

Sign up to save your podcasts

Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy

Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy

More shows like MS News & Perspectives

The Diary Of A CEO with Steven Bartlett